Institutional Ownership Utah Medical Products Inc (UTMD)
This table provides information about the institutional ownership of Utah Medical Products Inc (UTMD). We have compiled data on the 109 institutions that hold shares in the stock, with a total of 2.18 Million shares, which have been reported (via 13F filing form) to have a value of $124 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
221,510
shares
|
$12.6 Million
0.02% of portfolio
|
Q4 2024
Reduced 3.95%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
196,883
shares
|
$11.2 Million
0.0% of portfolio
|
Q2 2024
Reduced 8.17%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
186,700
shares
|
$10.6 Million
0.0% of portfolio
|
Q4 2024
Added 6.38%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
177,168
shares
|
$10 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.21%
|
|
Brandes Investment Partners, LP
La Jolla, CA |
Feb 10, 2025 Q4 2024 |
162,969
shares
|
$9.24 Million
0.12% of portfolio
|
Q4 2024
Added 17.78%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
97,937
shares
|
$5.55 Million
0.0% of portfolio
|
Q4 2024
Added 0.88%
|
|
Ranger Investment Management, L.P.
Dallas, TX |
Feb 13, 2025 Q4 2024 |
84,699
shares
|
$4.8 Million
0.34% of portfolio
|
Q4 2024
Reduced 2.14%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
82,698
shares
|
$4.69 Million
0.0% of portfolio
|
Q4 2024
Added 2.28%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
79,703
shares
|
$4.52 Million
0.0% of portfolio
|
Q4 2024
Added 14.83%
|
|
Rice Hall James & Associates, LLC
|
Jan 31, 2025 Q4 2024 |
78,808
shares
|
$4.47 Million
0.29% of portfolio
|
Q4 2024
Reduced 5.44%
|
|
Minerva Advisors LLC
Bala Cynwyd, PA |
Feb 04, 2025 Q4 2024 |
78,389
shares
|
$4.45 Million
3.27% of portfolio
|
Q4 2024
Added 85.19%
|
|
Hotchkis & Wiley Capital Management LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
75,180
shares
|
$4.26 Million
0.02% of portfolio
|
Q4 2024
Reduced 15.54%
|
|
Russell Investments Group, Ltd.
|
Feb 13, 2025 Q4 2024 |
43,201
shares
|
$2.45 Million
0.0% of portfolio
|
Q4 2024
Reduced 14.4%
|
|
Royce & Associates LP
|
Feb 10, 2025 Q4 2024 |
41,958
shares
|
$2.38 Million
0.03% of portfolio
|
Q4 2024
Added 158.95%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
36,832
shares
|
$2.09 Million
0.0% of portfolio
|
Q4 2024
Added 5.06%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
36,439
shares
|
$2.07 Million
0.0% of portfolio
|
Q4 2024
Added 11.79%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
32,087
shares
|
$1.82 Million
0.0% of portfolio
|
Q4 2024
Added 27.78%
|
|
Isthmus Partners, LLC
Madison, WI |
Feb 07, 2025 Q4 2024 |
31,464
shares
|
$1.78 Million
0.24% of portfolio
|
Q4 2024
Reduced 1.87%
|
|
Huber Capital Management LLC
El Segundo, CA |
Feb 12, 2025 Q4 2024 |
28,670
shares
|
$1.63 Million
0.36% of portfolio
|
Q4 2024
New holding
|
|
Los Angeles Capital Management LLC
|
Feb 04, 2025 Q4 2024 |
23,678
shares
|
$1.34 Million
0.01% of portfolio
|
Q4 2024
Reduced 22.5%
|
|
Bard Associates Inc
Chicago, IL |
Feb 06, 2025 Q4 2024 |
20,030
shares
|
$1.14 Million
0.49% of portfolio
|
Q4 2024
Added 1.26%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
20,000
shares
|
$1.13 Million
0.0% of portfolio
|
Q4 2024
Reduced 15.97%
|
|
Cardinal Capital Management
|
Jan 31, 2025 Q4 2024 |
19,784
shares
|
$1.12 Million
0.19% of portfolio
|
Q4 2024
Added 7.24%
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
19,190
shares
|
$1.09 Million
0.0% of portfolio
|
Q4 2024
Added 4.25%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
15,213
shares
|
$862,881
0.0% of portfolio
|
Q4 2024
Reduced 32.21%
|